Traveler's diarrhea: Updates for pediatricians

Pediatric Annals

Volumn 37, Issue 12, 2008, Pages 814-820

  Ang, Jocelyn Y ^a   Mathur, Ambika ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b Department of Pediatrics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETORPHAN; ATROPINE PLUS DIPHENOXYLATE; AZITHROMYCIN; BIFIDOBACTERIUM BIFIDUM EXTRACT; CHOLERA VACCINE; CIPROFLOXACIN; COTRIMOXAZOLE; DRINKING WATER; FURAZOLIDONE; INTERLEUKIN 8; LACTOBACILLUS ACIDOPHILUS EXTRACT; LACTOFERRIN; NALIDIXIC ACID; NITAZOXANIDE; PROBIOTIC AGENT; RIFAXIMIN; SACCHAROMYCES BOULARDII EXTRACT; UNCLASSIFIED DRUG; ANTIDIARRHEAL AGENT; ANTIINFECTIVE AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; DEFECATION URGENCY; DEHYDRATION; ENTERITIS; ENTEROAGGREGATIVE ESCHERICHIA COLI; FAMILY; FEVER; FOOD PREFERENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAND WASHING; HEMATOCHEZIA; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; IRRITABLE COLON; LOOSE FECES; MEDICAL INFORMATION; MUCUS SECRETION; NAUSEA; ORAL REHYDRATION THERAPY; SINGLE NUCLEOTIDE POLYMORPHISM; TENESMUS; TRAVEL; TRAVELLER DIARRHEA; UNSPECIFIED SIDE EFFECT; VOMITING; CHILD; DIARRHEA; DIET; VACCINATION;

ANTI-BACTERIAL AGENTS; ANTIDIARRHEALS; CHILD; DEHYDRATION; DIARRHEA; DIET; HUMANS; TRAVEL; VACCINATION;

EID: 59649090993     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20081201-06     Document Type: Article

References (45)

1. Gascón J. Epidemiology, etiology and pathophysiology of traveler's diarrhea. Digestion. 2006;73(Suppl 1):102-108.
2. Travelers' diarrhea. NIH Consensus Development Conference. JAMA. 1985;253(18):2700-2704.
3. DuPont HL, Capsuto EG. Persistent diarrhea in travelers. Clin Infect Dis. 1996;22(1):124-128.
4. Taylor DN, Connor BA, Shlim DR. Chronic diarrhea in the returned traveler. Med Clin North Am. 1999;83(4):1033-1052, vii.
5. Steffen R. Epidemiology of traveler's diarrhea. Clin Infect Dis. 2005;41(Suppl 8):S536-S540.
6. Cobelens FG, Leentvaar-Kuijpers A, Kleijnen J, Coutinho RA. Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice. Trop Med Int Health. 1998;3(11):896-903.
7. Hoge CW, Shlim DR, Echeverria P, Rajah R, Herrmann JE, Cross JH. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment JAMA. 1996;275(7):533-538.
8. Jiang ZD, Okhuysen PC, Guo DC, et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis. 2003;188(4):506-511.
9. Mohamed JA, DuPont HL, Jiang ZD, et al. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis. 2007;44(7):945-952.
10. Essers B, Burnens AP, Lanfranchini FM, et al. Acute community-acquired diarrhea requiring hospital admission in Swiss children. Clin Infect Dis. 2000;31(1):192-196.
11. Diemert DJ. Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev. 2006;19(3):583-594.
12. Adachi JA, Jiang ZD, Mathewson JJ, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis. 2001; 32(12):1706-1709.
13. Ogata K, Kato R, Ito K, Yamada S. Prevalence of Escherichia coli possessing the eaeA gene of enteropathogenic E. coli (EPEC) or the aggR gene of enteroaggregative E. coli (EAggEC) in traveler's diarrhea diagnosed in those returning to Tama, Tokyo from other Asian countries. Jpn J Infect Dis. 2002;55(1):14-18.
14. Feng P, Weagant SD, Monday SR. Genetic analysis for virulence factors in Escherichia coli O104:H21 that was implicated in an outbreak of hemorrhagic colitis. J Clin Microbiol. 2001;39(1):24-28.
15. Soderstrom A, Lindberg A, Andersson Y. EHEC O157 outbreak in Sweden from locally produced lettuce, August-September 2005. Euro Surveill. 2005;10(9):E050922 050921.
16. Ahmed AM, Kawamoto H, Inouye K, et al. Genomic analysis of a multidrug-resistant strain of enterohaemorrhagic Escherichia coli O157:H7 causing a family outbreak in Japan. J Med Microbiol. 2005;54(Pt 9):867-872.
17. Steffen R, van der Linde F, Gyr K, Schar M. Epidemiology of diarrhea in travelers. JAMA. 1983;249(9):1176-1180.
18. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med.1993;328(25):1821-1827.
19. Snell DM, Bartley C. Osmotic demyelination syndrome following rapid correction of hyponatraemia. Anaesthesia. 2008;63(1):92-95.
20. Grant HW, Hadley GP, Wiersma R, Rollins N. Surgical lessons learned from the Shigella dysenteriae type I epidemic. J R Coll Surg Edinb. 1998;43(3):160-162.
21. Connor BA. Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome. Clin Infect Dis. 2005;41(Suppl 8):S577-S586.
22. Yanai-Kopelman D, Paz A, Rippel D, Potasman I. Infl ammatory bowel disease in returning travelers. J Travel Med. 2000;7(6):333-335.
23. Yates JA, Stetz LC. Reiter's syndrome (reactive arthritis) and travelers' diarrhea. J Travel Med. 2006;13(1):54-56.
24. Ansdell VE, Ericsson CD. Prevention and empiric treatment of traveler's diarrhea. Med Clin North Am. Jul 1999;83(4):945-973, vi.
25. Mattila L, Siitonen A, Kyronseppa H, Simula II, Peltola H. Risk Behavior for Travelers' Diarrhea Among Finnish Travelers. J Travel Med. 1995;2(2):77-84.
26. Pitzinger B, Steffen R, Tschopp A. Incidence and clinical features of traveler's diarrhea in infants and children. Pediatr Infect Dis J. 1991;10(10):719-723.
27. Kozicki M, Steffen R, Schar M. 'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea? Int J Epidemiol. 1985;14(1):169-172.
28. sanofi pasteur Limited. Dukoral: Oral, Inactivated Travelers' Diarrhea and Cholera Vaccine (Oral Suspension). http://www.vaccineshoppecanada.com/secure/pdfs/ca/dukoral_e.pdf. Accessed November 17, 2008.
29. Glenn GM, Flyer DC, Ellingsworth LR, et al. Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert Rev Vaccines. 2007;6(5):809-819.
30. Hughes RJ. Dangers from hidden salicylates. Am Pharm. 1986;NS26(4):5.
31. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007;5(2):97-105.
32. Kligler B, Hanaway P, Cohrssen A. Probiotics in children. Pediatr Clin North Am. 2007;54(6):949-967; xi.
33. Gomi H, Jiang ZD, Adachi JA, et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother. 2001;45(1):212-216.
34. DuPont HL, Jiang ZD, Okhuysen PC, et al. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. Clin Infect Dis. 2005;41 Suppl 8:S571-S576.
35. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16.
36. Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea. Pediatrics. 2001;107(4):613-618.
37. Dale J. Oral rehydration solutions in the management of acute gastroenteritis among children. J Pediatr Health Care. 2004;18(4):211-212.
38. Ericsson CD. Travelers' diarrhea. Epidemiology, prevention, and self-treatment. Infect Dis Clin North Am. 1998;12(2):285-303.
39. Mackell S. Traveler's diarrhea in the pediatric population: etiology and impact. Clin Infect Dis. 2005;41(Suppl 8):S547-S552.
40. Keenum AJ, Stockton MD. Rifaximin (Xifaxan) for traveler's diarrhea. Am Fam Physician. 2005;72(12):2525-2526.
41. Anderson VR, Curran MP. Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs. 2007;67(13):1947-1967.
42. Hoge CW, Echeverria P, Rajah R, et al. Prevalence of Cyclospora species and other enteric pathogens among children less than 5 years of age in Nepal. J Clin Microbiol. 1995;33(11):3058-3060.
43. DuPont HL, Ericsson CD, Galindo E, et al. Furazolidone versus ampicillin in the treatment of traveler's diarrhea. Antimicrob Agents Chemother. 1984;26(2):160-163.
44. DuPont HL, Hornick RB. Adverse effect of lomotil therapy in shigellosis. JAMA. 1973;226(13):1525-1528.
45. Szajewska H, Ruszczynski M, Chmielewska A, Wieczorek J. Systematic review: racecadotril in the treatment of acute diarrhoea in children. Aliment Pharmacol Ther. 2007;26(6):807-813.